Advance Wound Care Market is projected to reach a valuation of US$ 17.4 Billion by 2032 | FMI

 The Advance Wound Care Market size is projected to be valued at US$ 11.5 Billion in 2023 and is expected to rise to US$ 17.4 Billion by 2033. The sales of advanced wound care are expected to grow at a significant CAGR of 4.2% during the forecast period.

The growing global geriatric population, as well as the growing incidences of ulcers, diabetic ulcers, and other chronic wounds, are key factors driving the market.

Advance Wound Care Market

Furthermore, the rising prevalence of diabetes and obesity, as well as a significant increase in the need for surgical procedures around the world, are fueling demand for advanced wound care products.

For more information @ https://www.futuremarketinsights.com/reports/advance-wound-care-market

In line with this, rising consumer awareness of the proven benefits and effectiveness of these products is driving up global sales.

In addition, technological developments in improved wound care products are fueling market expansion.

  • For instance, bioactive molecules across the applied area maintain the drug release and enhance the therapeutic benefits of pharmaceuticals in nanoparticle-based wound healing and skin regeneration.

The increase of ambulatory surgical centres (ASCs), which offer surgical care for pain management, orthopaedics, urology, restorative, organ transplantation, and reconstructive surgeries, is being driven by the expansion of these facilities.

Key Takeaways from the Automotive Refinish Coatings

  • Wound cleaner is expected to expand at the fastest rate (5.6%) among all items. Protection against loose debris and planktonic bacteria to create an ideal healing environment will boost the growth of the wound cleansers market.
  • Institutional sales are the most preferred distributional channel growing with an impressive rate of 4.8% due to an increase in surgical wound cases brought on by a rise in surgical procedures.
  • The U.S. will generate a revenue of USD 5.7 Bn by 2033 due to their advance healthcare setup and growing investments on healthcare technologies.
  • With a market share of more than 40% Asia Pacific advance wound care industry, India's advance wound care market is anticipated to expand at a CAGR of 6.4%. The rising number of product approvals and launches, distribution contracts, and mergers and acquisitions are all factors contributing to the country's growth.
  • It is projected that product releases and other strategic moves made by Japan's industry participants will hasten market expansion and contribute a revenue of USD 1.2 Bn by 2033.

Manufacturers are constantly evolving business models

With a large number of participants, the advanced wound care management market is extremely fragmented. Patients with chronic wounds enjoy better quality of life as technology develops and becomes more practical. Due to their efficiency and effectiveness in managing wounds by facilitating faster healing, modern wound care management and closure solutions are progressively replacing traditional wound care and closure treatments. In order to increase their market presence through mergers, acquisitions, partnerships, collaborations, new product launches, etc., industry players are concentrating on a variety of growth tactics.

Latest Developments

  • The 3M V.A.C. Therapy negative pressure wound therapy (NPWT) reached a clinical evidence milestone of 2,000 published, peer-reviewed medical journal articles in October 2022, according to a release from 3M Health Care's Medical Solutions Division. The first and only NPWT treatment to have as many published research about its therapy is V.A.C. Therapy.
  • Evonik and Coopmed, a medical technology consulting and sales organisation, signed a contract in September 2022 for the distribution of the wound dressing Epicite. Starting right away, Coopmed will only provide the German market with Epicite, a biosynthetic cellulose-based product for managing chronic wounds.

Some of the Key Players Operating in the Advance Wound Care Market Include:

  • Smith & Nephew
  • Molnlycke Health Care AB
  • ConvaTec Group PLC
  • Baxter International
  • URGO Medical
  • Coloplast Corp.
  • Medtronic
  • 3M
  • Derma Sciences Inc. (Integra LifeSciences)
  • Medline Industries

Key Segments Covered in the Advance Wound Care Market Report

Product :

  • Hydrogels Dressings
    • Antimicrobial Hydrogel Dressings
    • Non-Antimicrobial Hydrogel Dressings
  • Semi-Permeable Films Dressings
    • Semi-Permeable Films Dressings
    • Antimicrobial Bordered Film Dressings
    • Antimicrobial Non-Bordered Film Dressings
  • Semi-Permeable Films Dressings
    • Non-Antimicrobial Bordered Film Dressings
    • Non-Antimicrobial Non-Bordered Film Dressings
  • Alginate Dressings
    • Antimicrobial Alginate Dressings
    • Non-Antimicrobial Alginate Dressings
  • Foam Dressings
    • Antimicrobial Foam Dressings
    • Antimicrobial Bordered Foam Dressings
    • Antimicrobial Non-Bordered Foam Dressings
  • Non-Antimicrobial Foam Dressings
  • Hydrocolloid Dressings
    • Antimicrobial Hydrocolloid Dressings
    • Non-Antimicrobial Hydrocolloid Dressings
  • Collagen Dressings
    • Antimicrobial Collagen Dressing
    • Non-Antimicrobial Collagen Dressing
  • Contact Layer
    • Antimicrobial Wound Contact Layers
    • Non-Antimicrobial Wound Contact Layers
  • Super Absorbent Dressings
    • Antimicrobial Super Absorbent Dressings
    • Non-Antimicrobial Super Absorbent Dressings
  • Compression System
    • 2 Layer Compression System
    • 3 Layer Compression System
    • 4 Layer Compression System
  • Antimicrobial Gels
  • Antimicrobial Powder
  • Concentrated Surfactant
  • Skin Protectants
  • Wound Cleansers
  • Honey Dressings
  • Unna Boots
  • Tapes

Distribution Channel :

  • Institutional Sales
    • Hospitals
    • Long Term Care Centers
  • Retail Sales

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Primary Sclerosing Cholangitis (PSC) Market Size, Opportunities and Forecast 2023-2033

Image
  The global Primary Sclerosing Cholangitis (PSC) Market is anticipated to be worth US$ 151.07 million in 2023.  Primary Sclerosing Cholangitis (PSC) With growing alcohol consumption, the worldwide market for Primary Sclerosing Cholangitis (PSC) is expected to develop at a CAGR of 7.6% between 2023 and 2033, totaling roughly US$ 314.26 Million by 2033. According to the analysis of Future Market Insights, the Primary Sclerosing Cholangitis (PSC) market is expected to fuel over the analysis period, attributed to the factors such as the rise in the incidences of liver diseases, as well as rise in alcohol consumption. Get Full Access @ https://www.futuremarketinsights.com/reports/primary-sclerosing-cholangitis-psc-market  As per the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. As per the World Health Organization (WHO), prevalence of liver cirrhosis is increasing in the European countries, due to high con...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more